المؤلفون: Pietarinen, PO, Eide, CA, Ayuda-Duran, P, Potdar, S, Kuusanmaki, H, Andersson, EI, Mpindi, JP, Pemovska, T, Kontro, M, Heckman, CA, Kallioniemi, O, Wennerberg, K, Hjorth-Hansen, H, Druker, BJ, Enserink, JM, Tyner, JW, Mustjoki, S, Porkka, K

المصدر: Oncotarget. 8(14):22606-22615

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:135591884

المؤلفون: Zabriskie, MS, Eide, CA, Tantravahi, SK, Vellore, NA, Estrada, J, Nicolini, FE, Khoury, HJ, Larson, RA, Konopleva, M, Cortes, JE, Kantarjian, H, Jabbour, EJ, Kornblau, SM, Lipton, JH, Rea, D, Stenke, L, Barbany, G, Lange, T, Hernandez-Boluda, JC, Ossenkoppele, GJ, Press, RD, Chuah, C, Goldberg, SL, Wetzler, M, Mahon, FX, Etienne, G, Baccarani, M, Soverini, S, Rosti, G, Rousselot, P, Friedman, R, Deininger, M, Reynolds, KR, Heaton, WL, Eiring, AM, Pomicter, AD, Khorashad, JS, Kelley, TW, Baron, R, Druker, BJ, Deininger, MW, O'Hare, T

المصدر: Cancer cell. 26(3):428-442

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:129753343

المؤلفون: Xian, X, Sandhu, V, Eide, CA, Kurtz, SE, Malani, D, Erkers, T, Kallioniemi, O, Tyner, JW, Bhatt, S

المصدر: BLOOD. 142

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:155016914

المؤلفون: O'Hare T, Eide CA, Deiniger MW

المصدر: JNCI: Journal of the National Cancer Institute; 7/2/2008, Vol. 100 Issue 13, p908-909, 2p

المؤلفون: Snead JL, O'Hare T, Eide CA, Deininger MW

المصدر: Clinical Lymphoma & Myeloma; Mar2008 Supplement 3, Vol. 8, pS107-17, 1p

المؤلفون: Modak RV; Division of Oncological Sciences, Oregon Health & Science University, Portland, Oregon.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon.; Department of Cell, Developmental, & Cancer Biology, Oregon Health & Science University, Portland, Oregon., de Oliveira Rebola KG; Division of Oncological Sciences, Oregon Health & Science University, Portland, Oregon.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon.; Department of Cell, Developmental, & Cancer Biology, Oregon Health & Science University, Portland, Oregon., McClatchy J; Division of Oncological Sciences, Oregon Health & Science University, Portland, Oregon.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon.; Department of Cell, Developmental, & Cancer Biology, Oregon Health & Science University, Portland, Oregon., Mohammadhosseini M; Division of Oncological Sciences, Oregon Health & Science University, Portland, Oregon.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon.; Department of Cell, Developmental, & Cancer Biology, Oregon Health & Science University, Portland, Oregon., Damnernsawad A; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Department of Cell, Developmental, & Cancer Biology, Oregon Health & Science University, Portland, Oregon.; Department of Biology, Faculty of Science, Mahidol University, Bangkok, Thailand., Kurtz SE; Division of Oncological Sciences, Oregon Health & Science University, Portland, Oregon.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Department of Cell, Developmental, & Cancer Biology, Oregon Health & Science University, Portland, Oregon., Eide CA; Division of Oncological Sciences, Oregon Health & Science University, Portland, Oregon.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Wu G; Division of Bioinformatics & Computational Biology, Oregon Health & Science University, Portland, Oregon., Laderas T; Division of Bioinformatics & Computational Biology, Oregon Health & Science University, Portland, Oregon., Nechiporuk T; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Department of Cell, Developmental, & Cancer Biology, Oregon Health & Science University, Portland, Oregon., Gritsenko MA; Pacific Northwest National Laboratory, Richland, Washington., Hansen JR; Pacific Northwest National Laboratory, Richland, Washington., Hutchinson C; Pacific Northwest National Laboratory, Richland, Washington., Gosline SJC; Pacific Northwest National Laboratory, Richland, Washington.; Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, Oregon., Piehowski P; Pacific Northwest National Laboratory, Richland, Washington., Bottomly D; Division of Bioinformatics & Computational Biology, Oregon Health & Science University, Portland, Oregon., Short N; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas., Rodland K; Pacific Northwest National Laboratory, Richland, Washington., McWeeney SK; Division of Bioinformatics & Computational Biology, Oregon Health & Science University, Portland, Oregon., Tyner JW; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Department of Cell, Developmental, & Cancer Biology, Oregon Health & Science University, Portland, Oregon., Agarwal A; Division of Oncological Sciences, Oregon Health & Science University, Portland, Oregon.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon.; Department of Cell, Developmental, & Cancer Biology, Oregon Health & Science University, Portland, Oregon.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 15; Vol. 30 (10), pp. 2245-2259.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/metabolism , Leukemia, Myeloid, Acute*/pathology , Receptors, CCR2*/metabolism , Receptors, CCR2*/antagonists & inhibitors , Receptors, CCR2*/genetics , Drug Resistance, Neoplasm*/genetics , Chemokine CCL2*/metabolism , Chemokine CCL2*/genetics , Protein Kinase Inhibitors*/pharmacology , Protein Kinase Inhibitors*/therapeutic use , Signal Transduction*/drug effects, Humans ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Animals ; Pyridones/pharmacology ; Pyridones/therapeutic use ; Mice

المؤلفون: Eide CA; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Kurtz SE; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Division of Oncological Sciences, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Kaempf A; Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Long N; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Joshi SK; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Nechiporuk T; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Huang A; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Dibb CA; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Taylor A; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Bottomly D; Division of Bioinformatics and Computational Biomedicine, Department of Medical Informatics and Clinical Epidemiology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., McWeeney SK; Division of Bioinformatics and Computational Biomedicine, Department of Medical Informatics and Clinical Epidemiology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Minnier J; Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Lachowiez CA; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Saultz JN; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Swords RT; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Agarwal A; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Chang BH; Division of Pediatric Hematology and Oncology, Knight Cancer Institute, Doernbecher Children's Hospital, Oregon Health and Science University, Portland, Oregon., Druker BJ; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Division of Oncological Sciences, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Tyner JW; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Department of Cell, Developmental, and Cancer Biology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.

المصدر: Blood cancer discovery [Blood Cancer Discov] 2023 Nov 01; Vol. 4 (6), pp. 452-467.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/therapeutic use, Humans ; Proto-Oncogene Proteins c-bcl-2/genetics ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Azacitidine/pharmacology ; Azacitidine/therapeutic use

المؤلفون: Lucero OM; Department of Dermatology, Oregon Health & Science University, Portland, Oregon.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Lee JA; Clinical and Translational Science Institute, David Geffen School of Medicine, University of California, Los Angeles, California., Bowman J; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon., Johnson K; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon., Sapparapu G; Clinical and Translational Science Institute, David Geffen School of Medicine, University of California, Los Angeles, California., Thomas JK; Clinical and Translational Science Institute, David Geffen School of Medicine, University of California, Los Angeles, California., Fan G; Department of Pathology and Clinical Laboratory Medicine, Oregon Health & Science University, Portland, Oregon., Chang BH; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Pediatric Hematology and Oncology, Oregon Health & Science University, Portland, Oregon., Thiel-Klare K; Division of Pediatric Hematology and Oncology, Oregon Health & Science University, Portland, Oregon., Eide CA; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon., Okada C; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon., Palazzolo M; Clinical and Translational Science Institute, David Geffen School of Medicine, University of California, Los Angeles, California., Lind E; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, Oregon.; Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, Oregon., Kosaka Y; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Pediatric Hematology and Oncology, Oregon Health & Science University, Portland, Oregon., Druker BJ; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon.; VB Therapeutics LLC, Jackson, Wyoming., Lydon N; VB Therapeutics LLC, Jackson, Wyoming., Bowers PM; Therapeutic Antibody Laboratory, Department of Pulmonology and Critical Care, David Geffen School of Medicine, Los Angeles, California.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Oct 13; Vol. 29 (20), pp. 4230-4241.

نوع المنشور: Editorial; Comment

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Antigen, T-Cell*/genetics , Lymphoma, T-Cell*, Humans ; Mice ; Animals ; Rituximab ; T-Lymphocytes/immunology ; Receptors, Antigen, T-Cell, alpha-beta/genetics ; Receptors, Antigen, T-Cell, alpha-beta/immunology

المؤلفون: Barnes EJ; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA., Eide CA; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA., Kaempf A; Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA., Bottomly D; Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA., Romine KA; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA., Wilmot B; Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA., Saunders D; Flow Cytometry Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA., McWeeney SK; Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA., Tognon CE; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA., Druker BJ; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.

المصدر: British journal of haematology [Br J Haematol] 2023 Feb; Vol. 200 (3), pp. 323-328. Date of Electronic Publication: 2022 Oct 20.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Fusion Proteins, bcr-abl*/metabolism , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/metabolism, Humans ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Mutation ; Cell Line ; Drug Resistance, Neoplasm/genetics

المؤلفون: Gonzalez MA; Department of Molecular and Translational Medicine, Center of Emphasis in Cancer, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA., Olivas IM; Department of Molecular and Translational Medicine, Center of Emphasis in Cancer, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.; L. Frederick Francis Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA., Bencomo-Alvarez AE; Department of Molecular and Translational Medicine, Center of Emphasis in Cancer, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA., Rubio AJ; Department of Molecular and Translational Medicine, Center of Emphasis in Cancer, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA., Barreto-Vargas C; Immunology Division, University of Guadalajara, Guadalajara, Jalisco, Mexico., Lopez JL; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA., Dang SK; L. Frederick Francis Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA., Solecki JP; L. Frederick Francis Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA., McCall E; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA., Astudillo G; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA., Velazquez VV; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA., Schenkel K; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA., Reffell K; L. Frederick Francis Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA., Perkins M; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA., Nguyen N; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA., Apaflo JN; Metabolic, Nutrition and Exercise Research (MiNER) Laboratory, Department of Kinesiology, University of Texas at El Paso, El Paso, Texas, USA., Alvidrez E; Department of Pharmaceutical Sciences, School of Pharmacy, University of Texas at El Paso, El Paso, Texas, USA., Young JE; L. Frederick Francis Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA., Lara JJ; L. Frederick Francis Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA., Yan D; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah, USA., Senina A; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah, USA., Ahmann J; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah, USA., Varley KE; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah, USA., Mason CC; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah, USA., Eide CA; Knight Cancer Institute, Division of Hematology/Medical Oncology, Oregon Health & Science University, Portland, Oregon, USA., Druker BJ; Knight Cancer Institute, Division of Hematology/Medical Oncology, Oregon Health & Science University, Portland, Oregon, USA., Nurunnabi M; Department of Pharmaceutical Sciences, School of Pharmacy, University of Texas at El Paso, El Paso, Texas, USA., Padilla O; Department of Pathology, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA., Bajpeyi S; Metabolic, Nutrition and Exercise Research (MiNER) Laboratory, Department of Kinesiology, University of Texas at El Paso, El Paso, Texas, USA., Eiring AM; Department of Molecular and Translational Medicine, Center of Emphasis in Cancer, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.; L. Frederick Francis Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.

المصدر: Clinical and translational medicine [Clin Transl Med] 2022 Dec; Vol. 12 (12), pp. e1146.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet ISSN: 2001-1326 (Electronic) Linking ISSN: 20011326 NLM ISO Abbreviation: Clin Transl Med Subsets: MEDLINE

مواضيع طبية MeSH: Drug Resistance, Neoplasm*/genetics , Glycerophospholipids*/metabolism , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics , Cell Cycle Proteins*/genetics, Animals ; Mice ; Disease Progression ; Fusion Proteins, bcr-abl/genetics ; Genes, Switch ; Protein Kinase Inhibitors/therapeutic use ; Humans